Breast Cancer: Scientific and Clinical Progress Proceedings of the Biennial Conference for the International Association of Breast Cancer Research, Miami, Florida, USA — March 1–5, 1987

Effective control of breast cancer depends on three types of research accomplishment -- understanding the disease's origins and progression: successfully applying this knowledge to methods of detection, diagnosis and treatment: and finding ways to make these advances truly available to the publ...

Full description

Bibliographic Details
Other Authors: Rich, Marvin A. (Editor), Hager, Jean Carol (Editor), Lopez, Diana M. (Editor)
Format: eBook
Published: New York, NY Springer US 1988, 1988
Edition:1st ed. 1988
Series:Developments in Oncology
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • 20. Monoclonal Antibodies for Improved Evaluation of Breast Cancer Prognosis
  • 21. Hormone Receptors and Interactions Workshop Summary
  • IV New Perspectives in the Prevention and Control of Breast Cancer
  • 22. The Role of Diet in the Etiology and Causation of Breast Cancer
  • 23. Is Primary Prevention of Breast Cancer Achievable?
  • 24. Large Scale Screening Programs in Breast Cancer Prevention
  • 25. Successful Research Findings: What Comes Next?
  • I Oncogenes/Growth Factors—Their Role in Breast Cancer
  • 1. An Analysis of Three Proto-Oncogenes in Primary Human Breast Tumor DNAs: The c-mos, the C-erbB-2 and the Epidermal Growth Factor Receptor Genes
  • 2. Proviral Activation of Potential Oncogenes in Tumors Induced by Mouse Mammary Tumor Virus
  • 3. Quantitative and Qualitative Changes in Oncogene Expression During Carcinogenesis
  • 4. Mammary Tumor-Associated Growth Factors: Origins and Possible Functions
  • 5. The Oestrogen-Induced pS2 Gene and the Oestrogen Receptor in Breast Cancer
  • 6. Workshop on Oncogenes and Chemical Effectors of Neoplastic Transformation
  • II Mammary Gland Development, Differentiation and Pathology in Relationship to Malignancy
  • 7. Immunological Markers in the Study of the Development of the Mouse Mammary Gland and Its Tumors
  • 8. Cloning the Polymorphic Gene for the Mammary Mucin Abnormally Glycosylated in Carcinomas
  • 9. Regulation of Tissue-Specific Gene Expression in the Mammary Gland: The Role of the Extracellular Matrix
  • 10. The Possible Role of Abnormal Fibroblasts in the Pathogenesis of Breast Cancer
  • 11. Myoepithelial and Endocrine Differentiation in Breast Carcinoma
  • 12. Human Monoclonal Antibodies Directed Against Viral Antigens
  • 13. Cytotoxic Effector Mechanisms Involved in the Immunity Against Mammary Tumors
  • 14. Mesenchymal-Epithelial Interactions in Normal and Malignant Mammary Cells
  • 15. Breast Cancer Differentiation and Progression: Analysis with Monoclonal Antibodies and Flow Cytometry
  • III New Developments in Clinical Applications
  • 16. Mammary Epithelial Antigens as a Breakthrough in Breast Cancer Research: Now Where to?
  • 17. CA15-3 and Related Antigens as Serum Markers for Monitoring Breast Cancer
  • 18. Nuclear DNA Content and Prognosis in Breast Cancer
  • 19.Perspectives for the Clinical Use of Aromatase Inhibitors